about
Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features.Neuropsychiatric SLE: from animal model to human.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Belimumab therapy in systemic lupus erythematosus.
@en
type
label
Belimumab therapy in systemic lupus erythematosus.
@en
prefLabel
Belimumab therapy in systemic lupus erythematosus.
@en
P2860
P1433
P1476
Belimumab therapy in systemic lupus erythematosus.
@en
P2093
Eugene A Uy
Moncef Zouali
P2860
P2888
P304
P356
10.1007/S40259-013-0031-8
P577
2013-06-01T00:00:00Z